The public health response to the COVID-19 outbreak in mainland China: a narrative review.
Identifieur interne : 001671 ( Main/Corpus ); précédent : 001670; suivant : 001672The public health response to the COVID-19 outbreak in mainland China: a narrative review.
Auteurs : Mark Zanin ; Cheng Xiao ; Tingting Liang ; Shiman Ling ; Fengming Zhao ; Zhenting Huang ; Fangmei Lin ; Xia Lin ; Zhanpeng Jiang ; Sook-San WongSource :
- Journal of thoracic disease [ 2072-1439 ] ; 2020.
Abstract
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused nations to adopt unprecedented control measures in order to curb its spread. As the first nation to respond, China's aggressive control measures appeared to have been effective in suppressing the first wave and keeping new cases under control. Here, we provide the historical context and details of China's public health response to COVID-19. We highlight the lessons and impact of the 2002-2003 SARS outbreak, which demonstrated the importance of transparency, surveillance and testing laboratories during an outbreak. We provide an overview of China's response strategy that was based on the principles of early detection, isolation, management and treatment and involved not only the large-scale coordination of multiple governmental bodies but also grass-root community participation throughout the country. These community-based organizations conducted active surveillance for febrile cases and provided support for those in quarantine and communities in lockdown. Importantly, these broader measures were supported by digital technology, including the extensive use of internet-based platforms and mobile applications (APPs). While there have been no significant increases in case numbers since April, there is still much concern over a second wave, considering the resumption of work and school, the lifting of travel restrictions and the outbreaks occurring globally. Control measures has since been implemented by provincial authorities, which includes continued surveillance and rapid testing. Although China's strict control measures may not suit every nation, the principles of early detection and isolation continue to hold true and have been a cornerstone of the initial and ongoing response to the COVID-19.
DOI: 10.21037/jtd-20-2363
PubMed: 32944357
PubMed Central: PMC7475588
Links to Exploration step
pubmed:32944357Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The public health response to the COVID-19 outbreak in mainland China: a narrative review.</title><author><name sortKey="Zanin, Mark" sort="Zanin, Mark" uniqKey="Zanin M" first="Mark" last="Zanin">Mark Zanin</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Guangzhou Institute of Respiratory Health, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong, Hong Kong, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiao, Cheng" sort="Xiao, Cheng" uniqKey="Xiao C" first="Cheng" last="Xiao">Cheng Xiao</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Liang, Tingting" sort="Liang, Tingting" uniqKey="Liang T" first="Tingting" last="Liang">Tingting Liang</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Ling, Shiman" sort="Ling, Shiman" uniqKey="Ling S" first="Shiman" last="Ling">Shiman Ling</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhao, Fengming" sort="Zhao, Fengming" uniqKey="Zhao F" first="Fengming" last="Zhao">Fengming Zhao</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Huang, Zhenting" sort="Huang, Zhenting" uniqKey="Huang Z" first="Zhenting" last="Huang">Zhenting Huang</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Fangmei" sort="Lin, Fangmei" uniqKey="Lin F" first="Fangmei" last="Lin">Fangmei Lin</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Xia" sort="Lin, Xia" uniqKey="Lin X" first="Xia" last="Lin">Xia Lin</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Jiang, Zhanpeng" sort="Jiang, Zhanpeng" uniqKey="Jiang Z" first="Zhanpeng" last="Jiang">Zhanpeng Jiang</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wong, Sook San" sort="Wong, Sook San" uniqKey="Wong S" first="Sook-San" last="Wong">Sook-San Wong</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Guangzhou Institute of Respiratory Health, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong, Hong Kong, China.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32944357</idno><idno type="pmid">32944357</idno><idno type="doi">10.21037/jtd-20-2363</idno><idno type="pmc">PMC7475588</idno><idno type="wicri:Area/Main/Corpus">001671</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001671</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The public health response to the COVID-19 outbreak in mainland China: a narrative review.</title><author><name sortKey="Zanin, Mark" sort="Zanin, Mark" uniqKey="Zanin M" first="Mark" last="Zanin">Mark Zanin</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Guangzhou Institute of Respiratory Health, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong, Hong Kong, China.</nlm:affiliation></affiliation></author><author><name sortKey="Xiao, Cheng" sort="Xiao, Cheng" uniqKey="Xiao C" first="Cheng" last="Xiao">Cheng Xiao</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Liang, Tingting" sort="Liang, Tingting" uniqKey="Liang T" first="Tingting" last="Liang">Tingting Liang</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Ling, Shiman" sort="Ling, Shiman" uniqKey="Ling S" first="Shiman" last="Ling">Shiman Ling</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Zhao, Fengming" sort="Zhao, Fengming" uniqKey="Zhao F" first="Fengming" last="Zhao">Fengming Zhao</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Huang, Zhenting" sort="Huang, Zhenting" uniqKey="Huang Z" first="Zhenting" last="Huang">Zhenting Huang</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Fangmei" sort="Lin, Fangmei" uniqKey="Lin F" first="Fangmei" last="Lin">Fangmei Lin</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lin, Xia" sort="Lin, Xia" uniqKey="Lin X" first="Xia" last="Lin">Xia Lin</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Jiang, Zhanpeng" sort="Jiang, Zhanpeng" uniqKey="Jiang Z" first="Zhanpeng" last="Jiang">Zhanpeng Jiang</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wong, Sook San" sort="Wong, Sook San" uniqKey="Wong S" first="Sook-San" last="Wong">Sook-San Wong</name><affiliation><nlm:affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Guangzhou Institute of Respiratory Health, Guangzhou, China.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>School of Public Health, The University of Hong Kong, Hong Kong, China.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of thoracic disease</title><idno type="ISSN">2072-1439</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused nations to adopt unprecedented control measures in order to curb its spread. As the first nation to respond, China's aggressive control measures appeared to have been effective in suppressing the first wave and keeping new cases under control. Here, we provide the historical context and details of China's public health response to COVID-19. We highlight the lessons and impact of the 2002-2003 SARS outbreak, which demonstrated the importance of transparency, surveillance and testing laboratories during an outbreak. We provide an overview of China's response strategy that was based on the principles of early detection, isolation, management and treatment and involved not only the large-scale coordination of multiple governmental bodies but also grass-root community participation throughout the country. These community-based organizations conducted active surveillance for febrile cases and provided support for those in quarantine and communities in lockdown. Importantly, these broader measures were supported by digital technology, including the extensive use of internet-based platforms and mobile applications (APPs). While there have been no significant increases in case numbers since April, there is still much concern over a second wave, considering the resumption of work and school, the lifting of travel restrictions and the outbreaks occurring globally. Control measures has since been implemented by provincial authorities, which includes continued surveillance and rapid testing. Although China's strict control measures may not suit every nation, the principles of early detection and isolation continue to hold true and have been a cornerstone of the initial and ongoing response to the COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32944357</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2072-1439</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of thoracic disease</Title><ISOAbbreviation>J Thorac Dis</ISOAbbreviation></Journal><ArticleTitle>The public health response to the COVID-19 outbreak in mainland China: a narrative review.</ArticleTitle><Pagination><MedlinePgn>4434-4449</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/jtd-20-2363</ELocationID><Abstract><AbstractText>The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused nations to adopt unprecedented control measures in order to curb its spread. As the first nation to respond, China's aggressive control measures appeared to have been effective in suppressing the first wave and keeping new cases under control. Here, we provide the historical context and details of China's public health response to COVID-19. We highlight the lessons and impact of the 2002-2003 SARS outbreak, which demonstrated the importance of transparency, surveillance and testing laboratories during an outbreak. We provide an overview of China's response strategy that was based on the principles of early detection, isolation, management and treatment and involved not only the large-scale coordination of multiple governmental bodies but also grass-root community participation throughout the country. These community-based organizations conducted active surveillance for febrile cases and provided support for those in quarantine and communities in lockdown. Importantly, these broader measures were supported by digital technology, including the extensive use of internet-based platforms and mobile applications (APPs). While there have been no significant increases in case numbers since April, there is still much concern over a second wave, considering the resumption of work and school, the lifting of travel restrictions and the outbreaks occurring globally. Control measures has since been implemented by provincial authorities, which includes continued surveillance and rapid testing. Although China's strict control measures may not suit every nation, the principles of early detection and isolation continue to hold true and have been a cornerstone of the initial and ongoing response to the COVID-19.</AbstractText><CopyrightInformation>2020 Journal of Thoracic Disease. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zanin</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Institute of Respiratory Health, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, The University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Cheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Shiman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Fengming</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Zhenting</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Fangmei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Zhanpeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sook-San</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>State-Key Laboratory of Respiratory Diseases, Guangzhou Medical University, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guangzhou Institute of Respiratory Health, Guangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, The University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Thorac Dis</MedlineTA><NlmUniqueID>101533916</NlmUniqueID><ISSNLinking>2072-1439</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-2363). The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32944357</ArticleId><ArticleId IdType="doi">10.21037/jtd-20-2363</ArticleId><ArticleId IdType="pii">jtd-12-08-4434</ArticleId><ArticleId IdType="pmc">PMC7475588</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2020 Jun;26(6):1337-1339</Citation><ArticleIdList><ArticleId IdType="pubmed">32150527</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Jul 18;301(5631):294-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12869735</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2020 May 11;221(11):1757-1761</Citation><ArticleIdList><ArticleId IdType="pubmed">32067043</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2020 May 5;133(9):1015-1024</Citation><ArticleIdList><ArticleId IdType="pubmed">32004165</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2020 Mar;22(2):74-79</Citation><ArticleIdList><ArticleId IdType="pubmed">32017984</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Jun;10(6):1030-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15207054</ArticleId></ArticleIdList></Reference><Reference><Citation>Travel Med Infect Dis. 2020 Jan - Feb;33:101568</Citation><ArticleIdList><ArticleId IdType="pubmed">32006656</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2020 Jan 31;368:m406</Citation><ArticleIdList><ArticleId IdType="pubmed">32005675</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(1):0</Citation><ArticleIdList><ArticleId IdType="pubmed">32096367</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Apr 27;7(4):e1000266</Citation><ArticleIdList><ArticleId IdType="pubmed">20436959</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2006 Aug 19;333(7564):389-91</Citation><ArticleIdList><ArticleId IdType="pubmed">16916828</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2018 Apr 11;18(1):474</Citation><ArticleIdList><ArticleId IdType="pubmed">29642902</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Apr 21;323(15):1502-1503</Citation><ArticleIdList><ArticleId IdType="pubmed">32105304</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/LockdownV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001671 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001671 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= LockdownV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32944357
|texte= The public health response to the COVID-19 outbreak in mainland China: a narrative review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32944357" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LockdownV1
| This area was generated with Dilib version V0.6.38. |  |